Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial - Jorenby, D E; Hays, J T; Rigotti, N A (JAMA, 2006)
, et al; Varenicline Phase 3 Study Group.